
Decisions of the Annual General Meeting of shareholders of AB Linas Agro Group held on 27 October 2023
The Annual General Meeting (hereinafter – the Meeting) of AB Linas Agro Group (hereinafter – the Company) was held on 27 October 2023.
The total number of the Company’s shares is 161,085,933, the number of shares granting voting rights is 160,350,961, and the own shares in amount of 734,972 acquired by the Company do not grant voting rights.
In total 27 Company’s shareholders, who owned shares of the Company at the end of the Accounting day of the Meeting (20 October 2023), participated in the Meeting having 139,595,132 share votes, which amounted to 87.06 percent of the total number of the Company’s share votes.
26 duly filled General Voting Ballots were presented before the Meeting.
The Board member and CFO of the Company Mažvydas Šileika, deputizing Company’s CEO, participated in the Meeting.
The quorum existed.
Decisions of the Meeting:
1. Presentation of the Company’s Audit Committee Activity Report.
Presented (enclosed). No voting.
2. Presentation of the independent auditors’ report.
Presented (enclosed). No voting.
3. Presentation of the Consolidated Annual Report of the Company for the financial year 2022/2023.
Presented (enclosed). No voting.
4. Approval of the Company’s Remuneration Report.
Approve the Company’s Remuneration Report (enclosed).
Results of voting:
FOR – 139,595,132 votes (including 139,593,572 share votes of shareholders who voted in advance).
AGAINST – 0.
DID NOT VOTE – 0
5. Approval of the consolidated and the Company’s set of financial statements for the financial year ended 30 June, 2023.
Approve the consolidated and the Company‘s set of financial statements for the financial year ended 30 June, 2023 (enclosed).
Results of voting:
FOR – 139,595,132 votes (including 139,593,572 share votes of shareholders who voted in advance).
AGAINST – 0.
DID NOT VOTE – 0
6. Approval of the Distribution of the Company’s Profit (Loss).
Approve the Distribution of the Company’s Profit (Loss):
1) | Retained earnings – profit (loss) of the previous financial year at the end of the accounting financial year | EUR 45,829,293 |
2) | Net profit (loss) of the financial year | EUR 4 965 178 |
3) | The profit (loss) of the accounting financial year not recognized in the profit (loss) account | - |
4) | The transfers from the reserves | EUR 528,331 |
5) | The shareholder‘s contributions to cover the losses of the Company (if shareholders decided to cover all or part of losses) | - |
6) | The total profit (loss) available for appropriation | EUR 51,322,802 |
7) | The part of the profit allocated to the legal reserve | EUR 153,160 |
8) | The part of the profit allocated to the reserve of the own share acquisition | - |
9) | The part of the profit allocated to the reserve of shares issue | EUR 501,217 |
10) | The part of the profit allocated to the other reserves | - |
11) | The part of the profit allocated for the payment of dividends | EUR 4,169,125* |
12) | The part of the profit allocated for payment of annual bonuses to the Board, employees and other purposes | - |
13) | Retained earnings – profit at the end of the financial year carried forward to the next financial year | EUR 46,499,300 |
* Dividends in amount of EUR 4,169,125 are allocated for the financial year ended on 30 June, 2023, which consist EUR 0.026 with taxes per one share of the Company (calculated without own shares acquired by the Company).
Results of voting:
FOR – 139,595,132 votes (including 139,593,572 share votes of shareholders who voted in advance).
AGAINST – 0.
DID NOT VOTE – 0
7. Increase of the Company‘s share capital.
7.1. In accordance with provisions of AB Linas Agro Group rules for shares issue, to increase the share capital of the Company from EUR 46,714,920.57 up to EUR 48,479,439.49, by issuing 6,084,548 new ordinary registered book-entry shares with the par value of EUR 0.29 and issue price of 691,535 shares equal to EUR 0.705, and issue price of 5,393,013 shares equal to EUR 0,58, issued for the purpose of granting shares of the Company free of charge to the employees and/or members of the Company’s corporate bodies (the New Shares).
7.2. Establish that the total issue price of all New Shares equals to EUR 3,615,479.72 of which EUR 1,764,518.92 shall be the nominal value of the New Shares and EUR 1,850,960.80 shall be the share premium.
7.3. Establish that the New Shares are granted free of charge and they are paid by the Company from the reserve set up by the Company for shares issue.
7.4. Establish that right to subscribe and acquire the New Shares free of charge shall be granted to the employees and/or members of the corporate bodies of the Company who have concluded the Share Option Agreement of the Company in 2018 and in 2020 and accordingly in 2023 have submitted notice to the Company regarding the use of the option (the Option Holders). The list of Option Holders, who are entitled to acquire the New Shares is not published in order to ensure the protection of personal data.
7.5. Establish that each Option Holder to whom a right to subscribe for a certain number of the New Shares has been granted shall be informed hereof by the Head of the Company upon signing within 10 (ten) business days from the date of the resolutions adopted by the Meeting.
7.6. Establish that the Option Holders shall have a right to subscribe for a certain number of the New Shares by concluding share subscription agreement with the Company within 30 (thirty) days from the date of the resolutions adopted by the Meeting.
7.7. If during the period for the subscription of the New Shares not all the New Shares are subscribed, the share capital of the Company may be increased by the amount of the nominal values of the New Shares that have been subscribed.
7.8. Details of terms and conditions regarding the payment by the Company for the New Shares shall be provided in the share subscription agreement of the New Shares.
7.9. Authorize (including the power to delegate) the Chief Executive Officer of the Company to sign share subscription agreements with the Option Holders.
7.10. Considering that the Company seeks to grant shares of the Company free of charge to the employees and/or members of the corporate bodies of the Company who have concluded the Share Option Agreement of the Company and have submitted notice to the Company regarding the use of the option, to revoke pre-emption right of all shareholders of the Company to acquire the New Shares.
Results of voting:
FOR – 139,595,132 votes (including 139,593,572 share votes of shareholders who voted in advance).
AGAINST – 0.
DID NOT VOTE – 0
8. Changing the name of the Company.
Change the name of the Company from AB Linas Agro Group to AB Akola Group.
Results of voting:
FOR – 139,595,132 votes (including 139,593,572 share votes of shareholders who voted in advance).
AGAINST – 0.
DID NOT VOTE – 0
9. Approval of a new wording of the Articles of Association of the Company.
9.1. Taking into account the changing name and increase of the share capital of the Company, to amend the Articles of Association of the Company and approve a new wording of the Articles of Association (enclosed).
9.2. Authorize (including the power to delegate) the Chief Executive Officer of the Company to announce the Register of Legal Entities of the Republic of Lithuania about the decision to increase the share capital of the Company, to sign the new wording of the Articles of Association of the Company and to register them with the Register of Legal Entities of the Republic of Lithuania pursuant to the procedure under law, as well to perform other actions provided in the Law On Securities of the Republic of Lithuania and other applicable laws, and to sign other documents associated with the implementation of the resolutions adopted herein.
Results of voting:
FOR – 139,595,132 votes (including 139,593,572 share votes of shareholders who voted in advance).
AGAINST – 0.
DID NOT VOTE – 0
10. Election of the Company’s Audit Committee member.
Whereas the Audit Committee member Irma Antanaitienė submitted notice of resignation from the Audit Committee from 16 October, 2023, elect Arūnas Bartusevičius, an independent member the Supervisory Board, as a member of the Audit Committee of the Company until the end of current term of the Audit Committee.
Results of voting:
FOR – 139,595,132 votes (including 139,593,572 share votes of shareholders who voted in advance).
AGAINST – 0.
DID NOT VOTE – 0
11. Election of the Company‘s audit firm and setting conditions for payment for audit services.
11.1. Elect UAB ERNST & YOUNG BALTIC (code 110878442) as the audit firm of the Company for a period of 4 (four) years to perform audit of the consolidated and the Company’s annual financial statements.
11.2. Set a salary of EUR 72,000 (seventy two thousand euros), excluding VAT and additional expenses, for the audit of the 2023/24 financial year. For the audit of the financial year 2024/25, a salary of EUR 70,400 (seventy thousand four hundred euros) is set, excluding VAT and additional expenses, and is recalculated using the annual percentage change of the average gross salary of the financial and insurance activities in the private sector published by the State Data Agency. In each subsequent year, the salary is indexed by taking the previous salary. The annual size of the index will be fixed on June 30 of each year.
11.3. Authorize (including the power to delegate) the Chief Executive Officer of the Company to conclude and sign an agreement with the elected audit firm on behalf of the Company.
Results of voting:
FOR – 139,595,132 votes (including 139,593,572 share votes of shareholders who voted in advance).
AGAINST – 0.
DID NOT VOTE – 0
Mažvydas Šileika
CFO of AB Linas Agro Group
Mob. +370 619 19 403
E-mail m.sileika@linasagro.lt
Attachments
Independent auditor’s report
The Company's set of Annual Financial Statements and the Annual Report with Sustainability and Remuneration Reports
Articles of Association of AB Akola Group
CV of the new member of the Audit Committee
Audit Committee Activity Report
Attachments
- Independent Auditor's Report
- The Company's set of Annual Financial Statements and Annual Report with Sustainability and Remuneration Reports
- AB Akola Group Articles of Association
- CV of the new Member of the Audit Committee Arunas Bartusevicius
- Audit Committee Activity Report 2022/2023
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Scatec at COP28: Accelerating renewable energy transition from Egypt to South Africa2.12.2023 14:01:22 CET | Press release
Dubai, 2 December 2023: This week, Scatec ASA, a leading renewable energy company, is actively engaging in the UN Climate Change Conference in Dubai (COP28). Our focus is to underscore renewable energy as an unequivocal solution to climate change and emphasise the critical need for increased green energy investments in emerging markets. COP28 serves as a pivotal platform for global stakeholders to reinforce commitments aimed at averting catastrophic consequences of climate change. Scatec aligns with climate experts in stressing the urgency of the situation and the imperative to continue advancing towards the objectives outlined in the Paris Agreement. There's no time to waste, and collective progress is crucial for safeguarding our planet's future. “We are at COP28 to highlight the key role renewable energy must play in our energy future, "At COP28, our focus is on underscoring the crucial role renewable energy must assume in shaping our energy future, particularly in emerging markets,
Unplugged Performance Introduces UP INVINCIBLE®: A Game-Changer for Tesla Cybertruck Enthusiasts2.12.2023 05:06:20 CET | Press release
HAWTHORNE, Calif., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Unplugged Performance, the industry leader in performance upgrades for Tesla vehicles, debuts a new chapter in Tesla tuning with the arrival of their UP INVINCIBLE® product line. UP INVINCIBLE® is tailored exclusively for Tesla Cybertruck owners who want to push the limits of on-road and off-road performance. The unveiling took place at Unplugged Performance’s celebratory afterparty for Tesla's highly anticipated Cybertruck delivery event on November 30th. Hosted at the company's headquarters in Hawthorne, California, neighboring Tesla Design Studio, SpaceX, and Starlink, the event drew a capacity crowd, reflecting the immense enthusiasm for this innovative product range. UP INVINCIBLE® represents a concerted effort to harness and amplify the rugged DNA of the Cybertruck, making it even more robust and capable in a variety of challenging environments. During the event, Ben Schaffer, CEO of Unplugged Performance, presented an extensiv
Junshi Biosciences Announces New Chemical Entity Application for Toripalimab Accepted by Australia’s TGA2.12.2023 04:39:35 CET | Press release
SHANGHAI, China, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Therapeutic Goods Administration of the Australian Government Department of Health and Aged Care (TGA) has accepted the New Chemical Entity (NCE) application for toripalimab in combination with cisplatin and gemcitabine, for the first-line treatment of adults with metastatic or recurrent locally advanced nasopharyngeal carcinoma (NPC), and for toripalimab, as a single agent, for the treatment of adults with recurrent, unresectable, or metastatic NPC with disease progression on or after platinum-containing chemotherapy. Additionally, the TGA has also granted an orphan drug designation to toripalimab for the treatment of NPC. This NCE application was submitted through Project Orbis, an initiative of
Terra Balcanica Announces Private Placement Financing1.12.2023 23:00:00 CET | Press release
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Terra Balcanica Resources Corp. (“Terra” or the “Company”) (CSE:TERA) announces the intent to complete a non-brokered, private placement (“Private Placement”) for gross proceeds of up to $150,000 through the issuance of up to 3,750,000 common shares (“Common Shares”) at a purchase price of $0.04 per share. The Common Shares will be offered by way of prospectus exemptions in Canada and the Common Shares sold in the Private Placement will be subject to a hold period of four months plus one day. The Closing Date is expected to occur on or about December 11th, 2023, subject to regulatory approvals, including the approval by the CSE and certain other customary conditions including, but not limited to, execution of subscription agreements between the Company and the subscribers. The Private Placement will be utilized for opportuniti
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC1.12.2023 19:00:00 CET | Press release
Regulated Information Leuven, BELGIUM, Boston, MA, US – December 1, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, today announced that, pursuant to Belgian Transparency legislation1 it has received transparency notifications as follows: Oxurion received a first transparency notification on November 22, 2023, from Atlas Special Opportunities, LLC indicating that as of November 13, 2023, it held 0 shares of the then outstanding 3,112,043,514 shares, and therefore crossed below the threshold (3%) by virtue of the sale of voting securities. See Annex 1. Oxurion received a second transparency notification on November 29, 2023, from Atlas Special Opportunities, LLC indicating that as of November 17, 2023, it held 241,545,893 shares of the then outstanding 3,489,458,972 shares, and therefore crossed above the threshold (5%) by virtu